Overview

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Vaccines may make the body build an immune response to kill cancer cells. It is not yet known which regimen of chemotherapy combined with vaccine therapy is more effective for non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to determine the effectiveness of combination chemotherapy followed by vaccine therapy plus sargramostim in treating patients who have stage III or stage IV non-Hodgkin's lymphoma.

Phase:

Phase 3

Details

Lead Sponsor:

Genitope Corporation

Treatments:

Antibodies
Cyclophosphamide
Immunoglobulin Idiotypes
Immunoglobulins
Immunoglobulins, Intravenous
Keyhole-limpet hemocyanin
Prednisone
Sargramostim
Vaccines
Vincristine